Ignite Creation Date:
2024-05-05 @ 11:23 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00010413
Status:
COMPLETED
Last Update Posted:
2008-10-02
First Post:
2001-02-02
Brief Title:
Phase II Study of High-Dose Cyclophosphamide in Patients With Refractory Pemphigus
Sponsor:
Johns Hopkins University
Organization:
Office of Rare Diseases ORD
Organization Data
Organization:
Office of Rare Diseases ORD
Class:
NIH
Study ID:
19915674
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Johns Hopkins University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None